システイン欠乏に関連した急速な体重減少
Alan Varghese1,2, Ivan Gusarov2, Begoña Gamallo-Lana3
1Department of Cell Biology, NYU Grossman School of Medicine, New York, NY, USA.
Nature
|May 21, 2025
まとめ
システインの制限は,ストレス反応を活性化し,コエンザイムA (CoA) を枯渇させることで,マウスの体重を著しく減少させます. 肥満や代謝疾患に対する 潜在的戦略を提示しています
科学分野:
- 代謝に関する研究
- 肥満と体重管理
- 栄養学的生化学
背景:
- 肥満はアメリカの人口の40%と 世界の人口の6人に"人に 影響を及ぼし 効果的な治療が必要になっています
- 炭水化物,脂肪,アミノ酸の制限のようなダイエット戦略が検討されています.
- 体重プロファイルに対する個々のアミノ酸の制限の具体的な影響については,さらなる調査が必要である.
研究 の 目的:
- マウスの体重プロファイルに対する個々のアミノ酸の制限の影響を調査する.
- どのアミノ酸の制限が 最も重要な体重減少をもたらすかを特定する.
- 体重の変化を誘発する分子と代謝メカニズムを解明する.
主な方法:
- マウスモデルにおける個々のアミノ酸の条件付き制限
- 体重の変化と代謝パラメータの評価
- 統合ストレス反応と酸化ストレス反応を含むストレス反応経路の分析
- 組織内のコエンザイムA (CoA) レベルとミトコンドリア機能の測定
- 泌尿器排泄物の代謝分析
主要な成果:
- 条件付きのシステインの制限により,1週間以内にマウスの体重が30%減ったが,これは逆転可能であった.
- システイン欠乏は統合的および酸化的ストレス反応を活性化し,GDF15およびFGF21を誘発した.
- 組織内のCoA濃度が低下し,ミトコンドリアの機能が低下し,代謝の再配線が起こりました.
- 非効率的な無酸素糖分解,トリカルボキシル酸循環,主要な代謝物の尿による持続的排泄が観察されました.
結論:
- システインの制限は,GSHとCoAの枯渇によって,他のアミノ酸の制限と比較して,体重減少,代謝,およびストレスシグナルに最大限の影響を及ぼします.
- この発見は,代謝調節と体重管理におけるシステインの重要な役割を強調しています.
- この研究は肥満と関連する代謝障害に対処するための新しい戦略を示唆しています.
関連する概念動画
01:21Overview of Protein Metabolism
646
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
646
01:24Cystic Fibrosis: Management
136
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
136
01:23Cystic Fibrosis: Pathogenesis
174
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
174
01:22Lysosomal Hydrolases
3.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.7K
01:20Inborn Errors of Metabolism
121
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
121